RSLS logo

ReShape Lifesciences (RSLS) Net Margin

Annual Net Margin

-131.22%
+279.94%+68.09%

December 31, 2023


Summary


Performance

RSLS Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRSLSprofitabilitymetrics:

Quarterly Net Margin

-68.98%
+12.19%+15.02%

September 30, 2024


Summary


Performance

RSLS Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRSLSprofitabilitymetrics:

Net Margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

RSLS Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+68.1%+57.9%
3 y3 years+31.4%+85.5%
5 y5 years+99.0%+52.0%

RSLS Net Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+71.7%at high+94.1%
5 y5-yearat high+73.3%at high+94.1%
alltimeall timeat high+99.0%at high+100.0%

ReShape Lifesciences Net Margin History

DateAnnualQuarterly
Sep 2024
-
-68.98%(-15.0%)
Jun 2024
-
-81.17%(-28.0%)
Mar 2024
-
-112.81%(+31.7%)
Dec 2023
-131.22%(-68.1%)
-85.67%(-47.8%)
Sep 2023
-
-163.99%(+5.8%)
Jun 2023
-
-154.97%(+33.1%)
Mar 2023
-
-116.40%(-78.0%)
Dec 2022
-411.16%(-11.4%)
-529.55%(+21.6%)
Sep 2022
-
-435.53%(+33.4%)
Jun 2022
-
-326.56%(-1.8%)
Mar 2022
-
-332.58%(-71.5%)
Dec 2021
-464.31%(+142.5%)
-1167.12%(+144.5%)
Sep 2021
-
-477.32%(+331.7%)
Jun 2021
-
-110.57%(-26.9%)
Mar 2021
-
-151.32%(-43.1%)
Dec 2020
-191.43%(-61.1%)
-266.17%(+85.1%)
Sep 2020
-
-143.78%(-32.1%)
Jun 2020
-
-211.75%(+37.0%)
Mar 2020
-
-154.57%(-75.0%)
Dec 2019
-491.80%
-618.69%(-24.4%)
DateAnnualQuarterly
Sep 2019
-
-818.04%(+128.7%)
Jun 2019
-
-357.75%(+145.7%)
Mar 2019
-
-145.61%(-97.6%)
Dec 2018
-13.37 K%(+125.0%)
-6147.33%(-93.0%)
Sep 2018
-
-87.56 K%(-75.2%)
Jun 2018
-
-352.51 K%(+4262.0%)
Mar 2018
-
-8081.30%(-36.1%)
Dec 2017
-5941.73%(+100.1%)
-12.65 K%(+355.6%)
Sep 2017
-
-2775.87%(-62.2%)
Jun 2017
-
-7350.29%(-60.0%)
Mar 2017
-
-18.40 K%(+488.7%)
Dec 2016
-2969.62%(-66.0%)
-3125.06%(+42.2%)
Sep 2016
-
-2197.89%(+21.4%)
Jun 2016
-
-1809.84%(-82.4%)
Mar 2016
-
-10.29 K%(+126.5%)
Dec 2015
-8732.45%(+15.9%)
-4543.82%(-29.9%)
Sep 2015
-
-6485.42%(-30.8%)
Jun 2015
-
-9371.85%(+256.4%)
Dec 2012
-7531.50%
-
Jun 2012
-
-2629.27%(-42.5%)
Mar 2012
-
-4576.22%

FAQ

  • What is ReShape Lifesciences annual net profit margin?
  • What is the all time high annual net margin for ReShape Lifesciences?
  • What is ReShape Lifesciences annual net margin year-on-year change?
  • What is ReShape Lifesciences quarterly net profit margin?
  • What is the all time high quarterly net margin for ReShape Lifesciences?
  • What is ReShape Lifesciences quarterly net margin year-on-year change?

What is ReShape Lifesciences annual net profit margin?

The current annual net margin of RSLS is -131.22%

What is the all time high annual net margin for ReShape Lifesciences?

ReShape Lifesciences all-time high annual net profit margin is -131.22%

What is ReShape Lifesciences annual net margin year-on-year change?

Over the past year, RSLS annual net profit margin has changed by +279.94% (+68.09%)

What is ReShape Lifesciences quarterly net profit margin?

The current quarterly net margin of RSLS is -68.98%

What is the all time high quarterly net margin for ReShape Lifesciences?

ReShape Lifesciences all-time high quarterly net profit margin is -68.98%

What is ReShape Lifesciences quarterly net margin year-on-year change?

Over the past year, RSLS quarterly net profit margin has changed by +95.01% (+57.94%)